We are live on ! Find out more
LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Lumos Pharma, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 28 → 0 (-28)

100% less capital invested

Capital invested by funds: $8.08M → $0 (-$8.08M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 28

Holders
–
Holders Change
-28
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
28
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PAG
Private Advisor Group
New Jersey
-$2.88M
2
Goldman Sachs
Goldman Sachs
New York
-$1.4M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$945K
4
Renaissance Technologies
Renaissance Technologies
New York
-$827K
5
JFG
Jefferies Financial Group
New York
-$467K
Name Holding Trade Value Shares
Change 		Change in
Stake
PAG
1
Private Advisor Group
New Jersey
– -$2.88M -744,513 Closed
Goldman Sachs
2
Goldman Sachs
New York
– -$1.4M -362,198 Closed
Vanguard Group
3
Vanguard Group
Pennsylvania
– -$945K -244,082 Closed
Renaissance Technologies
4
Renaissance Technologies
New York
– -$827K -213,814 Closed
JFG
5
Jefferies Financial Group
New York
– -$467K -120,651 Closed
GWM
6
Greenwich Wealth Management
Connecticut
– -$295K -76,341 Closed
Wells Fargo
7
Wells Fargo
California
– -$251K -64,981 Closed
Geode Capital Management
8
Geode Capital Management
Massachusetts
– -$213K -55,148 Closed
BlackRock
9
BlackRock
New York
– -$154K -39,825 Closed
LPC
10
Lion Point Capital
New York
– -$153K -39,589 Closed
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
– -$97.8K -25,278 Closed
BCM
12
Bridgeway Capital Management
Texas
– -$76K -19,643 Closed
Bank of New York Mellon
13
Bank of New York Mellon
New York
– -$45.9K -11,858 Closed
WAOI
14
Wealth Advisors of Iowa
Iowa
– -$45.3K -11,699 Closed
State Street
15
State Street
Massachusetts
– -$43.5K -11,237 Closed
Two Sigma Investments
16
Two Sigma Investments
New York
– -$43.1K -11,130 Closed
KFI
17
Key Financial Inc
Pennsylvania
– -$42.3K -10,927 Closed
ACM
18
ADAR1 Capital Management
Texas
– -$38.7K -10,000 Closed
UBS Group
19
UBS Group
Switzerland
– -$25.4K -6,557 Closed
PAG
20
Paladin Advisory Group
Iowa
– -$17K -4,387 Closed
Bank of America
21
Bank of America
North Carolina
– -$6.97K -1,800 Closed
TRCT
22
Tower Research Capital (TRC)
New York
– -$4.74K -1,225 Closed
WFA
23
West Financial Advisors
Iowa
– -$3.04K -784 Closed
Osaic Holdings
24
Osaic Holdings
Arizona
– -$1.12K -290 Closed
Morgan Stanley
25
Morgan Stanley
New York
– -$642 -166 Closed
1
2

LUMO Hedge Fund Activity: Q4 2024 in Review

0 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q4 2024, worth a combined $0 — down 100% from $8.08M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of LUMO and 0 opened new positions — a net loss of 28 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Private Advisor Group, exiting entirely with an estimated $2.88M sold.

  • 0 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q4 2024, down from 28 in Q3 2024.
  • Funds reported $0 of Lumos Pharma, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Lumos Pharma, Inc. Common Stock positions in Q4 2024 and 28 closed out, a net change of -28 holders.
  • The largest Lumos Pharma, Inc. Common Stock seller in Q4 2024 was Private Advisor Group, an estimated $2.88M sold.

Based on aggregated 13F filings for Q4 2024.